The drug we have developed inhibits the hydrolysis of acetylcholine in the brain, alleviating symptoms in dogs suffering from canine cognitive impairment, which is dementia-like Alzheimer’s disease.

Details about the Technology offer (click)

For more information contact Knowledge Transfer Office of the University of Ljubljana.